How do you pay?

How to pay the least

Ask for the cash price

Inluriyo

We didn’t find one.

  1. Ask your pharmacy for Inluriyo’s cash price, and one or two other pharmacies too.
  2. Inluriyo’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify Lilly Cares Foundation Patient Assistance Program. Note: These income limits are 300% (Group 1 Medications), 400% (Group 2 Medications), and 500% (Group 3 & 4 Medications) of 2026 Federal Poverty Guidelines. Or call 1-800-545-6962.

See if you qualify 

Compare every option

Question
Brand nameInluriyo
Authorized genericimlunestrant
Regular genericimlunestrant
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Inluriyo?
The original
–
–

Brand nameThe maker’s card

Inluriyo Savings Card

Savings card from Eli Lilly

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

The card takes up to $10,600 a year off your co-pay.

Sign up on enrollment.inluriyo.lilly.com 

Or call 1-844-583-3550. See the offer on inluriyo.lilly.com

In the maker’s words

“Pay as little as $0 per month with the Inluriyo® (imlunestrant) Savings Card, if eligible and commercially insured with coverage for Inluriyo.”

From the maker’s offer on inluriyo.lilly.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Inluriyo itself, from the same company, sold without the brand name, and usually for less. For now Inluriyo is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

INLURIYO® is an estrogen receptor antagonist indicated:

  • as monotherapy for the treatment of adults with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer, as detected by an FDA-authorized test, with disease progression following at least one line of endocrine therapy
  • in combination with abemaciclib for the treatment of adults with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer, as detected by an FDA-authorized test, with disease progression following at least one line of endocrine therapy

Source: the FDA label for Inluriyo (Eli Lilly and Company), September 18, 2026. Full label on DailyMed 

Good to know